From the Editor-in-Chief
More basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
Editor's Letter
How can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
Forward Look
Putting the Immune System in Overdrive | Weighty Matters | A Blood Test for Cancer | Melanoma Risk Increased in Some Lymphoma Survivors | Aspirin Recommended to Reduce Colorectal Cancer Risk | Fine-Tuning Treatments for Triple-Negative Breast Cancer | Don't Get Burned
Your Cancer Guide
Complementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
Caregiving With Confidence
Follow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Practical Pointers
Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
Pain is no gain for patients during or after cancer treatment.
by Sue Rochman
Survivor Profile
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
Healthy Habits
What's The Beef? | Less Stress
Q&A
Cancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
Sound Advice
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
Get Involved!
Give patients and their families a break from cancer.
by Maria Wolf
Colleen Bokor, Dana Stewart, Brittany Avin.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Can discussion of health inequities lead to actionable change?
by Marci A. Landsmann
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR